IBRX shares jump 10% after a deal with Saudi Arabia

Immunitybio Inc (IBRX) shares jumped nearly 10% pre-market on Thursday following an agreement with a Saudi associate to expand Anktiva in the Middle East and North Africa. This major deal with Saudi Arabia continues the narrative of an improving financial year for 2025. Despite the positive news, IBRX stock remains down over 12% over the last 12 months.